📢 New Podcast Feature: Augur Associates on The GCS LAB (01/02/2026)

We’re excited to share that Augur Associates was recently featured on The GCS LAB Podcast, hosted by Christopher Tasker of Global Cannabinoid Solutions (GCS), a platform focused on science-led cannabis strategy and policy insights. In this episode, titled “Leading the Next Phase of French Cannabis with Industry Leaders Augur Associates”, Benjamin-Alexandre Jeanroy and Aurélien Bernard join the discussion to unpack the real dynamics shaping France’s emerging medical cannabis market, beyond the headlines.

🎧 What’s Covered in the Conversation

• Why France matters: The podcast explores how France is quietly becoming one of the most consequential cannabis markets in Europe, with regulatory complexity that demands a deeper understanding rather than oversimplified narratives.

• Insights from our research: Benjamin and Aurélien share key takeaways from Augur Associates’ 2025 detailed market report, including what the current medical trials reveal, where bottlenecks persist, and how policy evolution is unfolding behind the scenes.

• Real opportunities & challenges: The conversation goes beyond hype to highlight where genuine opportunities lie in French cannabis policy and market development, from governance and evidence to industry infrastructure.

This episode is essential listening for anyone interested in European cannabis policy, healthcare systems, investment strategy, or science-based market development, especially those following developments in France.

Watch the full episode on YouTube to hear the full discussion and get deeper insights into what “the next phase” of medical cannabis in France could look like.